Transient partial response to sorafenib treatment in an adolescent patient with MEN2B syndrome and end-stage medullary thyroid carcinoma. [electronic resource]
Producer: 20120112Description: 98-100 p. digitalISSN:- 1545-5017
- Adolescent
- Antineoplastic Agents -- therapeutic use
- Benzenesulfonates -- therapeutic use
- Carcinoma, Medullary -- drug therapy
- Female
- Humans
- Multiple Endocrine Neoplasia Type 2b -- complications
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Prognosis
- Pyridines -- therapeutic use
- Sorafenib
- Thyroid Neoplasms -- drug therapy
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.